In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
University of Edinburgh researchers bring us a step closer to space bacon
In Scotland, researchers from the University of Edinburgh’s Roslin Institute have created a pig cell line capable of producing fat cells with “remarkable consistency”...
Lab-grown leather pioneer Faircraft acquires assets from DiCaprio-backed VitroLabs
In Paris, biotech start-up Faircraft has announced the acquisition of key assets from U.S.-based VitroLabs, a pioneering player in the lab-grown leather industry that...
Teysha outfits Everest team with biodegradable eyewear
In the United Kingdom, Teysha Technologies is supplying four former special forces soldiers with biodegradable sunglasses as they attempt a world record on the...